You're signed outSign in or to get full access.
Capricorn Fund Managers LTD
Capricorn Fund Managers Ltd is a London-based hedge fund and investment management firm headquartered at 2nd Floor, Malta House, 36-38 Piccadilly, London, United Kingdom. The firm manages a range of alternative investment strategies and primarily serves institutional investors and high-net-worth individuals. Detailed headcount is not disclosed in public filings, but as a specialist alternatives manager, it typically maintains a small to mid-sized team. Capricorn Fund Managers Ltd is authorized and regulated in major jurisdictions and files regular reports with the SEC as an institutional asset manager.
Investment Strategy
Capricorn Fund Managers Ltd focuses on alternative investment strategies, including diversified, market-neutral, and hedged equity approaches. The firm is known for employing a fundamental, research-driven process that focuses on identifying long and short opportunities across global equities. Its strategy seeks to achieve absolute returns regardless of market direction by applying rigorous risk management and portfolio construction principles, primarily serving institutional clients and high-net-worth investors.
Latest 13F Filing Activity
Capricorn Fund Managers LTD filed their most recent 13F report on Sep 30, 2025 disclosing 58 equity positions with a total 13F market value of $298M. The fund increased holdings in Waystar Holding Ord, Tarsus Pharmaceuticals, Vera Therapeutics CL A Ord among other positions. Capricorn Fund Managers LTD reduced exposure to Dick's Sporting Goods, Sharkninja Ord, Tapestry among others.
Top Holdings
Equity Positions (58)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
W WAY | WAYSTAR HOLDING ORD | 6.43% | $19.2M | 505,122 | $37.92 | $37.92 | +$19.2M |
T TARS | Tarsus Pharmaceuticals | 4.79% | $14.3M | 240,020 | $59.43 | $59.43 | +$14.3M |
M MSFT | Microsoft Corp | 4.75% | $14.1M | 27,318 | $414.33 | $517.95 | +$3.4M |
V VERA | VERA THERAPEUTICS CL A ORD | 4.40% | $13.1M | 450,700 | $29.06 | $29.06 | +$13.1M |
R REAL | RealReal (The) | 4.25% | $12.6M | 1,189,490 | $3.97 | $10.63 | +$4.9M |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more